Impact of body mass index on treatment efficacy of mirabegron for overactive bladder in females. [electronic resource]
- European journal of obstetrics, gynecology, and reproductive biology Jan 2016
- 64-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1872-7654
10.1016/j.ejogrb.2015.11.018 doi
Acetanilides--therapeutic use Aged Body Mass Index Female Humans Middle Aged Risk Factors Thiazoles--therapeutic use Treatment Outcome Urinary Bladder, Overactive--drug therapy Urological Agents--therapeutic use